(BNS) Bank of Nova Scotia - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA0641491075

Banking, Loans, Mortgages, Investments, Insurance

Dividends

Dividend Yield 4.31%
Yield on Cost 5y 7.82%
Yield CAGR 5y 4.12%
Payout Consistency 93.9%
Payout Ratio 60.3%
Risk via 10d forecast
Volatility 17.9%
Value at Risk 5%th 29.0%
Relative Tail Risk -1.63%
Reward TTM
Sharpe Ratio 1.75
Alpha 30.05
CAGR/Max DD 0.81
Character TTM
Hurst Exponent 0.495
Beta 0.397
Beta Downside 0.267
Drawdowns 3y
Max DD 24.53%
Mean DD 7.17%
Median DD 7.63%

Description: BNS Bank of Nova Scotia December 03, 2025

The Bank of Nova Scotia (NYSE:BNS) is a diversified Canadian bank with operations across North America, Latin America, the Caribbean, and select international markets. It serves retail and commercial customers through four segments-Canadian Banking, International Banking, Global Wealth Management, and Global Banking & Markets-offering a full suite of products from deposit accounts and credit cards to mortgages, business loans, trade finance, and wealth-management services.

As of its latest earnings release (Q3 2024), BNS reported a net income of CAD 3.2 billion and a Common Equity Tier 1 (CET1) ratio of 13.1%, comfortably above the regulatory minimum. The bank’s earnings are highly sensitive to the North American interest-rate environment and to commodity-linked activity in its Latin-American operations, both of which have shown volatility in 2024. Digital adoption continues to accelerate, with mobile-banking transactions now representing roughly 55% of total retail activity, a trend that could improve cost efficiency if sustained.

For a deeper, data-driven assessment of BNS’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (7.21b TTM) > 0 and > 6% of Revenue (6% = 4.43b TTM)
FCFTA 0.01 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -1125 % (prev 122.7%; Δ -1247 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.01 (>3.0%) and CFO 18.79b > Net Income 7.21b (YES >=105%, WARN >=100%)
Net Debt (414.35b) to EBITDA (11.17b) ratio: 37.09 <= 3.0 (WARN <= 3.5)
Current Ratio 0.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.25b) change vs 12m ago 0.81% (target <= -2.0% for YES)
Gross Margin 42.48% (prev 13.72%; Δ 28.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 5.24% (prev 3.86%; Δ 1.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.25 (EBITDA TTM 11.17b / Interest Expense TTM 37.85b) >= 6 (WARN >= 3)

Altman Z'' -3.61

(A) -0.59 = (Total Current Assets 191.81b - Total Current Liabilities 1022.49b) / Total Assets 1414.69b
(B) 0.04 = Retained Earnings (Balance) 58.70b / Total Assets 1414.69b
(C) 0.01 = EBIT TTM 9.47b / Avg Total Assets 1408.53b
(D) 0.06 = Book Value of Equity 75.26b / Total Liabilities 1329.20b
Total Rating: -3.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 55.06

1. Piotroski 3.0pt
2. FCF Yield 4.50%
3. FCF Margin 25.01%
4. Debt/Equity 5.78
5. Debt/Ebitda 37.09
6. ROIC - WACC (= -0.66)%
7. RoE 8.59%
8. Rev. Trend 85.07%
9. EPS Trend -54.32%

What is the price of BNS shares?

As of December 08, 2025, the stock is trading at USD 71.70 with a total of 1,454,012 shares traded.
Over the past week, the price has changed by +3.48%, over one month by +9.47%, over three months by +14.41% and over the past year by +36.02%.

Is BNS a buy, sell or hold?

Bank of Nova Scotia has received a consensus analysts rating of 3.47. Therefor, it is recommend to hold BNS.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 10
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the BNS price?

Issuer Target Up/Down from current
Wallstreet Target Price 63.8 -11.1%
Analysts Target Price 63.8 -11.1%
ValueRay Target Price 80.6 12.5%

BNS Fundamental Data Overview December 03, 2025

Market Cap CAD = 118.30b (85.63b USD * 1.3815 USD.CAD)
P/E Trailing = 18.3342
P/E Forward = 12.0192
P/S = 2.7015
P/B = 1.5816
P/EG = 1.5706
Beta = 1.274
Revenue TTM = 73.86b CAD
EBIT TTM = 9.47b CAD
EBITDA TTM = 11.17b CAD
Long Term Debt = 192.39b CAD (from longTermDebt, last quarter)
Short Term Debt = 291.66b CAD (from shortTermDebt, last quarter)
Debt = 484.05b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 414.35b CAD (from netDebt column, last quarter)
Enterprise Value = 410.53b CAD (118.30b + Debt 484.05b - CCE 191.81b)
Interest Coverage Ratio = 0.25 (Ebit TTM 9.47b / Interest Expense TTM 37.85b)
FCF Yield = 4.50% (FCF TTM 18.47b / Enterprise Value 410.53b)
FCF Margin = 25.01% (FCF TTM 18.47b / Revenue TTM 73.86b)
Net Margin = 9.76% (Net Income TTM 7.21b / Revenue TTM 73.86b)
Gross Margin = 42.48% ((Revenue TTM 73.86b - Cost of Revenue TTM 42.48b) / Revenue TTM)
Gross Margin QoQ = 46.16% (prev 41.97%)
Tobins Q-Ratio = 0.29 (Enterprise Value 410.53b / Total Assets 1414.69b)
Interest Expense / Debt = 1.78% (Interest Expense 8.63b / Debt 484.05b)
Taxrate = 24.70% (829.0m / 3.36b)
NOPAT = 7.13b (EBIT 9.47b * (1 - 24.70%))
Current Ratio = 0.19 (Total Current Assets 191.81b / Total Current Liabilities 1022.49b)
Debt / Equity = 5.78 (Debt 484.05b / totalStockholderEquity, last quarter 83.80b)
Debt / EBITDA = 37.09 (Net Debt 414.35b / EBITDA 11.17b)
Debt / FCF = 22.43 (Net Debt 414.35b / FCF TTM 18.47b)
Total Stockholder Equity = 83.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.51% (Net Income 7.21b / Total Assets 1414.69b)
RoE = 8.59% (Net Income TTM 7.21b / Total Stockholder Equity 83.97b)
RoCE = 3.43% (EBIT 9.47b / Capital Employed (Equity 83.97b + L.T.Debt 192.39b))
RoIC = 1.89% (NOPAT 7.13b / Invested Capital 377.22b)
WACC = 2.55% (E(118.30b)/V(602.35b) * Re(7.48%) + D(484.05b)/V(602.35b) * Rd(1.78%) * (1-Tc(0.25)))
Discount Rate = 7.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.39%
[DCF Debug] Terminal Value 76.38% ; FCFE base≈16.01b ; Y1≈14.19b ; Y5≈11.81b
Fair Price DCF = 172.4 (DCF Value 214.18b / Shares Outstanding 1.24b; 5y FCF grow -14.04% → 3.0% )
EPS Correlation: -54.32 | EPS CAGR: -3.46% | SUE: 0.79 | # QB: 0
Revenue Correlation: 85.07 | Revenue CAGR: 25.81% | SUE: 1.43 | # QB: 3
EPS next Quarter (2026-01-31): EPS=1.94 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-10-31): EPS=7.96 | Chg30d=+0.051 | Revisions Net=+6 | Growth EPS=+13.8% | Growth Revenue=+3.7%

Additional Sources for BNS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle